
Today we announce our first commercial partnership, with
@CybinInc, to explore the promise of psychedelic pharmaceutical therapies for mental health, charting a new course in psychiatry.
Today we announce our first commercial partnership, with
@CybinInc, to explore the promise of psychedelic pharmaceutical therapies for mental health, charting a new course in psychiatry.